Metocard-CHT 50 Tablet ER
Metocard-CHT 50 Tablet ER
Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Metocard-CHT 50 Tablet ER: Comprehensive Blood Pressure Management
Metocard-CHT 50 Tablet ER combines the strengths of three key medications to provide comprehensive blood pressure management. This extended-release tablet contains a precise blend of Chlorthalidone (12.5mg), Metoprolol Succinate (50mg), and Telmisartan (40mg), delivering targeted control for hypertension.
* Chlorthalidone: Works by increasing urine output to lower blood volume and pressure.
* Metoprolol Succinate: A beta-blocker that slows heart rate and reduces the workload of your heart.
* Telmisartan: An angiotensin II receptor blocker (ARB) that relaxes blood vessels, reducing peripheral resistance and lowering blood pressure.
This combined therapy offers a unique approach to blood pressure control, potentially benefiting patients with various stages and types of hypertension. The extended-release formulation ensures gradual release and longer-lasting efficacy throughout the day.
Note: Consult with a healthcare professional for proper diagnosis and treatment recommendations. This description is for informational purposes only and should not replace medical advice or prescriptions.
Active composition
Chlorthalidone 12.5 mg
+2 more active ingredients
All Active Ingredients
Telmisartan
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Metoprolol Succinate
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Metocard-CHT 50 Tablet ER.
High Risk
Pregnancy
Metocard-CHT 50 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Metocard-CHT 50 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Metocard-CHT 50 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Metocard-CHT 50 Tablet ER may be needed. Please consult your doctor. Use of Metocard-CHT 50 Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Metocard-CHT 50 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Metocard-CHT 50 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Metocard-CHT 50 Tablet ER may be needed. Please consult your doctor. Use of Metocard-CHT 50 Tablet ER is not recommended in these patients.
Regular Checkup
Customer Reviews
0 reviews for Metocard-CHT 50 Tablet ER
Products matching your search
Olmezest H 40 Tablet
Olmezest H 40 Tablet
Enzorab 20 Tablet
Enzorab 20 Tablet
G-Triglim 2 Tablet SR
G-Triglim 2 Tablet SR
Olkem 20H Tablet
Olkem 20H Tablet
Enzoxy Max Capsule
Enzoxy Max Capsule
Fepanil-Mef DS Oral Suspension Delicious Orange
Fepanil-Mef DS Oral Suspension Delicious Orange
Foxin Eye Drop
Foxin Eye Drop
Losartas 25 Tablet